Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections.
about
Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence TherapyHost factors that contribute to recurrent staphylococcal skin infectionPathogenesis of Staphylococcus aureus abscessesThe S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens.Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation.Simple Wound Irrigation in the Postoperative Treatment for Surgically Drained Spontaneous Soft Tissue Abscesses: Study Protocol for a Prospective, Single-Blinded, Randomized Controlled Trial.Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation.Autophagy mediates tolerance to Staphylococcus aureus alpha-toxin.Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing.Methicillin-resistant Staphylococcus aureus adaptation to human keratinocytesProteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin InfectionCD36 Is Essential for Regulation of the Host Innate Response to Staphylococcus aureus α-Toxin-Mediated Dermonecrosis.Prevention of Recurrent Staphylococcal Skin InfectionsSynergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal SepsisThe ever-emerging complexity of α-toxin's interaction with host cellsAntibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesisImportance of B Lymphocytes and the IgG-Binding Protein Sbi in Staphylococcus aureus Skin Infection.Innate Immune Memory Contributes to Host Defense against Recurrent Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus.The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.α-Toxin Regulates Local Granulocyte Expansion from Hematopoietic Stem and Progenitor Cells in Staphylococcus aureus-Infected Wounds.Bacterial toxins: Offensive, defensive, or something else altogether?Neutralizing α-toxin accelerates healing of Staphylococcus aureus-infected wounds in normal and diabetic mice.Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314.Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection.
P2860
Q26752975-3F9137C9-3124-49AA-BFA2-7F5507D7B65EQ27005777-61FDEE98-05D3-4C4E-B5FE-DC0D5823DCC8Q28080781-2293821E-22A6-4DEB-B0E6-F69AC14841EBQ29994694-CD043FFC-0DBD-44F7-9CBE-FFA2F5455BD3Q30239977-9FC22155-C73F-4782-A618-D7ACDAF6875BQ33677615-FB681005-FF16-497A-A9FD-1BFF59C5EDF5Q33690186-3DAA999C-044A-42F0-9701-8B902E07BD8DQ34922452-22821A12-03DE-417A-B8D9-9D9C385A0AEFQ35169008-8895F1BA-F488-484F-8126-DE6313149916Q35356667-1F402BF7-0AB8-4E76-BB00-A89BC4D4921CQ35622488-D3CCB892-DF26-4D2D-B27F-1335CD62BF22Q35677564-3A40C282-4873-42A7-8CBD-7DEB6C61915DQ35947359-366E4EDD-7483-44EB-80C2-C568FC55EEFAQ35988737-1A7DA8BA-24F8-4A13-AB2A-BBF82BD808DAQ36005464-5168F7EE-52F5-498A-B4F1-DB79BCAB0EE3Q36274821-921A0161-65AE-452C-B24E-FB24F861C418Q36306086-A0263923-4697-418B-BBB7-2501662B9D78Q36609408-71BEB40F-7AED-4BB8-93C7-07C9DDECBB63Q36636170-C089620A-B464-406A-92C4-BCCD900662DDQ36735408-6B3E5E99-0B6F-4B42-A068-86B7D71D36B6Q37611964-4C5FE71B-06EC-4A97-A384-C8154DE415D1Q38805996-23C54603-477F-4255-81A1-FEAB95FC5F2DQ39173330-FA1C6020-F4D8-454A-9051-24CB524326E3Q40124323-7A5AD9F2-30D7-4FA4-B63A-88F97FD9BA3EQ41995627-EAD029AB-ED83-4C27-BD81-2BEB1D158B9EQ47193259-B3A3A524-965F-481F-8C1A-189A6CFC65D9Q48319147-D2E10E7C-1BD1-4775-B0FD-DF161278E754Q50199724-1903BA52-24A3-4671-80AA-FFC201E63B34
P2860
Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@ast
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@en
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@nl
type
label
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@ast
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@en
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@nl
prefLabel
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@ast
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@en
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@nl
P2093
P2860
P356
P1476
Targeting Staphylococcus aureu ...... in and soft-tissue infections.
@en
P2093
Andrea C DeDent
Bryan J Berube
Georgia R Sampedro
Hongyuan Cao
Juliane Bubeck Wardenburg
Michael J Gebhardt
Russell E N Becker
P2860
P304
P356
10.1093/INFDIS/JIU223
P407
P577
2014-04-16T00:00:00Z